Select Medical Holdings Corporation (NYSE: SEM) Seen Running Too Hot, Let’s Look At This More Closely

Currently, there are 129.54M common shares owned by the public and among those 109.65M shares have been available to trade.

The company’s stock has a 5-day price change of -0.96% and -11.63% over the past three months. SEM shares are trading -1.06% year to date (YTD), with the 12-month market performance up to 32.78% higher. It has a 12-month low price of $13.94 and touched a high of $22.07 over the same period. SEM has an average intraday trading volume of 1.19 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -4.08%, -3.39%, and -1.60% respectively.

Institutional ownership of Select Medical Holdings Corporation (NYSE: SEM) shares accounts for 82.13% of the company’s 129.54M shares outstanding.

It has a market capitalization of $2.41B and a beta (3y monthly) value of 1.56. The stock’s trailing 12-month PE ratio is 8.70, while the earnings-per-share (ttm) stands at $2.14. The company has a PEG of 0.90 and a Quick Ratio of 1.13 with the debt-to-equity ratio at 2.39. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.41% over the week and 2.93% over the month.

Earnings per share for the fiscal year are expected to increase by 35.50%, and -25.72% over the next financial year. EPS should shrink at an annualized rate of 9.70% over the next five years, compared to 13.25% over the past 5-year period.

BofA Securities coverage for the Select Medical Holdings Corporation (SEM) stock in a research note released on August 20, 2024 offered a Buy rating with a price target of $42. The Benchmark Company was of a view on May 13, 2021 that the stock is Buy, while BofA Securities gave the stock Buy rating on February 26, 2021, issuing a price target of $30- $36. BofA/Merrill on their part issued Underperform rating on June 16, 2020.

Most Popular

Related Posts